AdaptHealth Corp.

NASDAQ:AHCO

Medical - Devices

Healthcare
$7.37 +0.10%

+$0.01 today

Market cap
$1.01B
Beta
1.46
P/E (TTM)
-16.3
EPS (TTM)
-$0.59
52W Low $8.06High $13.43

Volume 1.54M

Average 1.38M

AHCO Depreciation & Amortization

Non-cash asset write-downs added back to net income because no cash left the business.

AdaptHealth Corp.NASDAQ: AHCO

Depreciation & Amortization · Q1 FY2026 · quarter ended Apr 2026

Depreciation & amortization growth accelerates

Q1 FY2026 depreciation & amortization of $117.31M rose 24.3% year over year, ahead of the +10.6% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 20.3% from the prior quarter. Over 3 fiscal years it compounded at +2.8% a year.

Context

  • Depreciation & amortization amounted to 11.8% of revenue in FY2025, up 0.6 pp from a year earlier.
  • Depreciation & amortization increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +24.3% holds above the trailing-twelve-month pace of +10.6%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterApr 2026
$117.31M+20.3% QoQ
Last fiscal yearDec 2025
$381.93M+4.5% YoY
LTMApr 2026
$416.38M+10.6% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+24.3%——
1 year+4.5%——
3-year CAGR+2.8%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the cash flow

Latest · FY2025
381.93M USD
Year-over-year change
+4.5%
4-year CAGR
+10.3%

Depreciation & Amortization vs competitors

How AHCO compares with its peers on the latest reported figures

  • AHCO's LTM Apr 2026 depreciation & amortization of $416.38M is the largest of the 9 companies compared; the peer median is $17.16M.
  • Its year-over-year change of +10.6% is the 5th highest of 9, against a peer median of +8.2%.
  • Depreciation & amortization amounts to 14.6% of revenue for AHCO, versus a peer median of 3.5%.
AHCO Competitors Peer median
Depreciation & Amortization for AHCO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AHCOAdaptHealth Corp.LTM Apr 2026$416.38M +10.6%+2.8%14.6%
RMDResMed Inc.LTM Jun 2026$244.15M +3.5%+7.3%4.3%
VMDViemed Healthcare, Inc.LTM Mar 2026$29.62M +15.3%+22.3%10.3%
INGNInogen, Inc.LTM Mar 2026$20.37M -2.6%-4.2%5.8%
INSPInspire Medical Systems, Inc.LTM Jun 2026$17.21M +59.5%+95.8%1.9%
TNDMTandem Diabetes Care, Inc.LTM Mar 2026$17.11M -1.1%-1.2%1.7%
INFUInfuSystem Holdings, Inc.LTM Mar 2026$13.25M +2.4%-0.2%9.3%
BBNXBeta Bionics, Inc.LTM Mar 2026$2.94M +26.6%+11.3%2.7%
ELMDElectromed, Inc.LTM Mar 2026$1.11M +12.8%+23.1%1.5%
Peer median (excluding AHCO) $17.16M+8.2%+9.3%3.5%

Competitors are the stored peer set for AHCO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income158.15M73.13M(678.9M)94.78M(66.04M)
Depreciation & Amortization258.05M351.18M420.59M365.33M381.93M
Deferred Income Tax22.38M18.04M(62.6M)32.05M47.16M
Stock-Based Compensation25.32M22.4M22.47M14.88M21.88M
Change in Working Capital(153.31M)(108M)(25.11M)(26.06M)66.58M
Accounts Receivables(29.69M)(209K)(28.86M)(26.22M)30.99M
Inventory(14.92M)(6.3M)15.53M(28.07M)(11.49M)
Accounts Payables00000
Other Working Capital(108.7M)(101.49M)(11.78M)28.22M47.08M
Other Non-Cash Items(34.92M)17.12M804.2M60.86M150.26M
Operating Cash Flow275.68M373.87M480.67M541.84M601.77M
Capital Expenditures(203.31M)(391.42M)(337.46M)(306.06M)(382.39M)
Acquisitions (Net)(1.62B)(19.02M)(19.69M)(9.54M)(42.38M)
Purchases of Investments(1.13M)(731K)(128K)00
Sales of Investments00000
Other Investing Activities0005.32M121.58M
Investing Cash Flow(1.82B)(411.17M)(357.28M)(310.28M)(303.19M)
Debt Repayment1.4B(36.18M)(51.77M)(179.87M)(268.48M)
Common Stock Issued278.85M0001.21M
Common Stock Repurchased0(13.99M)(29.28M)00
Dividends Paid00000
Other Financing Activities(75.68M)(15.88M)(11.48M)(19.08M)(34.93M)
Financing Cash Flow1.6B(66.05M)(92.53M)(198.95M)(302.19M)
Effect of Forex Changes00000
Net Change in Cash49.67M(103.36M)30.86M32.62M(3.61M)
Free Cash Flow72.37M(17.56M)143.2M235.78M219.38M

AdaptHealth Corp.

NASDAQ:AHCO

Intrinsic Alpha fair value

Locked

Current Price

$7.37

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.